|
|
Volumn 121, Issue 1, 2003, Pages 195-196
|
|
Antibody-targeted chemotherapy of relapsed AML [4]
|
|
Author keywords
Acute myeloid leukaemia (AML); Antibody targeted chemotherapy; Complete remission; Gemtuzumab ozogamicin; Older patients
|
|
Indexed keywords
CD33 ANTIGEN;
CYTARABINE;
GEMTUZUMAB OZOGAMICIN;
IDARUBICIN;
MITOXANTRONE;
ACUTE GRANULOCYTIC LEUKEMIA;
AGED;
ALOPECIA;
ANAMNESIS;
ANTIBODY DETECTION;
BLAST CELL;
BLOOD SAMPLING;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER RESISTANCE;
CANCER SURVIVAL;
CARDIOTOXICITY;
CASE REPORT;
CHEMOTHERAPY INDUCED EMESIS;
CHILL;
CLINICAL FEATURE;
COMORBIDITY;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG INFUSION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
ERYTHROCYTE TRANSFUSION;
FEVER;
HUMAN;
KIDNEY FAILURE;
LABORATORY TEST;
LETTER;
LIVER TOXICITY;
MALE;
MUCOSA INFLAMMATION;
NAUSEA;
NEUROTOXICITY;
NEUTROPENIA;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENT CANCER;
SIDE EFFECT;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ACUTE DISEASE;
AGED;
AMINOGLYCOSIDES;
ANTI-BACTERIAL AGENTS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC;
HUMANS;
IMMUNOTHERAPY;
LEUKEMIA, MYELOID;
MALE;
RECURRENCE;
TREATMENT OUTCOME;
|
|
EID: 0344511756
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2003.04245_4.x Document Type: Letter |
|
Times cited : (2)
|
|
References (4)
|
